What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Stock indices move on earnings, policy changes, and macro data. This intro covers the core catalysts that drive daily swings.
23,761 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Chevron has kept its promise to shareholders with steady cash returns. Discover how 16 quarters of returns totaling o...
Four pure-play quantum stocks slid 6%–9% in a coordinated downturn, signaling a sector-wide rotation amid broader mar...
A timely analysis of pff’s billion preferred stock exposure reveals how call provisions and a bank-heavy portfolio co...
When a seasoned fund doubles down on a single stock, it sends a clear message. Frontier Capital Management recently e...
A formerly troubled telehealth stock is catching fresh attention from investors. This article explores the bull case,...
In June, the stock market faces a delicate balance between AI excitement and real-world demand. Broadcom’s results sh...
A high-profile insider sale at Amplitude raises questions for investors. This guide breaks down what amplitude's co-f...
A large open-market sale by Indivior's Chief Scientific Officer sparked questions about future risk and long-term val...
In June’s shifting markets, automation stocks like UiPath are under the microscope. This article explains why ARR gro...
Rocket Lab just hit a new speed record with its Victus Haze mission, signaling potential shifts in the space-launch m...
A major market moment is shaping up as Dan Ives weighs in on SpaceX’s potential public debut. This article breaks dow...